株探米国株
英語
エドガーで原本を確認する
6-K 1 evo_6k.htm FORM 6-K evo_6k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE MONTH OF JANUARY 2024

 

COMMISSION FILE NUMBER 001-34041

 

Evotec SE

(Translation of registrant’s name into English)

 

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F: Form 20‑F ☒ Form 40‑F ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7): ☐

 






 

DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K

 

Explanatory Note

 

On January 03, 2024, Evotec SE issued an Ad-Hoc announcement stating that CEO Dr Werner Lanthaler has informed the company that he has decided to step down as CEO and will not continue to serve until the end of his current term. A copy of the Ad-Hoc announcement is attached as Exhibit 99.1 hereto. A copy of the accompanying press release is attached as Exhibit 99.2 hereto.

 

 
2

 

 

SIGNATURE

 

Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Evotec SE

 

 

By:

/s/ Laetitia Rouxel

 

Name: Laetitia Rouxel

 

Title: Chief Financial Officer

 

Date: 03rd January 2024

 

 
3

 

 

EXHIBIT INDEX

 

Exhibit

 

Description of Exhibit

 

99.1

 

Evotec announces CEO transition

99.2

 

Evotec announces CEO transition

 

 
4

 

EX-99.1 2 evo_ex991.htm EVOTEC ANNOUNCES evo_ex991.htm

EXHIBIT 99.1

 

Evotec announces CEO transition

 

Hamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces that CEO Dr Werner Lanthaler has informed the company, that he has decided to step down as CEO and will not continue to serve until the end of his current term, for personal reasons. The Supervisory Board has accepted his resignation from his office.

 

Werner Lanthaler will continue to be available as a strategic advisor to the company’s Supervisory Board. Dr Mario Polywka, former COO and currently member of the Supervisory Board has agreed to step in as interim CEO.

 

Evotec confirms guidance 2023.

 

– End of the ad hoc release –

 

Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 19405058, volker.braun@evotec.com

 

EX-99.2 3 evo_ex992.htm EVOTEC ANNOUNCES evo_ex992.htm

EXHIBIT 99.2